Business Context and Reporting Period
Kochav Defense Acquisition Corp. (KCHV) is a Cayman Islands exempted corporation incorporated on January 7, 2025, operating as a Special Purpose Acquisition Company (SPAC). The company intends to effect a business combination with one or more businesses in the defense and aerospace industries. This Form 10-Q covers the period from inception (January 7, 2025) through March 31, 2025. As of the balance sheet date, the company had not commenced operations and had no operating revenues.
Key Financial Metrics
| Metric | Value (Period Ended March 31, 2025) |
|---|---|
| Total Assets | $143,625 |
| Total Liabilities | $140,387 |
| Shareholder's Equity | $3,238 |
| Net Loss | $(21,762) |
| Cash and Cash Equivalents | $0 |
| Working Capital Deficit | $(115,387) |
| Outstanding Class B Shares | 8,433,333 |
Note: The company had no cash on hand as of March 31, 2025. Liquidity was supported by a promissory note from the Sponsor.
Material Changes and Subsequent Events
The most significant development occurred subsequent to the reporting period. On May 29, 2025, the company consummated its Initial Public Offering (IPO) and related private placement:
- IPO Proceeds: Sold 25,300,000 Public Units at $10.00 per unit, generating gross proceeds of $253,000,000. This included the full exercise of the underwriters' over-allotment option.
- Private Placement: Sold 524,050 Private Placement Units to the Sponsor at $10.00 per unit, generating $5,240,500.
- Trust Account: $253,000,000 was deposited into a Trust Account.
- Transaction Costs: Total transaction costs were $11,024,267, comprising a $3,415,500 cash underwriting fee, a $6,957,500 deferred underwriting fee, and $651,267 in other offering costs.
- Debt Repayment: The company borrowed an additional $207,494 under the related-party promissory note and repaid the full amount of $207,494 on June 2, 2025.
Outlook, Risks, and Management Commentary
Outlook and Strategy: The company intends to use funds held in the Trust Account to complete a business combination. It has 18 months from the IPO closing (May 29, 2025) to complete a transaction, extendable by up to two additional three-month periods (total 24 months) at the Sponsor's option without shareholder approval. If no combination is completed, the company will liquidate and redeem public shares.
Risks and Contingencies:
- Geopolitical Instability: The filing highlights risks associated with the Russia-Ukraine and Israel-Hamas conflicts, which could cause market volatility, supply chain interruptions, and impact the search for a target.
- Going Concern: Prior to the IPO, the company had a working capital deficit. Management determined that post-IPO proceeds are sufficient to finance working capital needs for at least one year.
- Sponsor Indemnity: The Sponsor has agreed to indemnify the company against claims that reduce Trust Account funds below $10.00 per share, though the company has not verified the Sponsor's ability to satisfy this obligation.
Investor Verification Checklist
- IPO Closing Confirmation: Verify the final closing date and exact proceeds deposited into the Trust Account via the Form 8-K filed on June 4, 2025.
- Trust Account Investments: Confirm the specific composition of investments (U.S. Treasury obligations vs. money market funds) and current interest rates affecting the redemption value.
- Deferred Underwriting Fee: Note the $6,957,500 deferred fee payable only upon a successful business combination; this is a contingent liability.
- Extension Rights: Review the specific terms regarding the Sponsor's ability to extend the completion window without shareholder approval.
- Founder Share Forfeiture: Confirm that the 1,100,000 founder shares previously subject to forfeiture are now fully vested due to the full exercise of the over-allotment option.